Thanks to Jax6002 for the link to businessinsider
Post# of 148185
(Total Views: 596)
Posted On: 08/21/2020 5:29:10 PM
Thanks to Jax6002 for the link to businessinsider article. The JAMA article on Remdesivir moderate study is below.
https://jamanetwork.com/journals/jama/article....67456.pdf
Patients put on a 10-day course of remdesivir didn't improve more than patients who didn't get the drug; they also died at the same rates. And although patients on remdesivir did report fewer severe symptoms of COVID-19 overall, they also experienced more minor to moderate symptoms and side effects. in a commentary accompanying the new study, Erin McCreary and Derek Angus, two researchers at the University of Pittsburgh Medical Center, said the new findings raise a question about "whether the drug is less efficacious than hoped."
https://jamanetwork.com/journals/jama/article....67456.pdf
Patients put on a 10-day course of remdesivir didn't improve more than patients who didn't get the drug; they also died at the same rates. And although patients on remdesivir did report fewer severe symptoms of COVID-19 overall, they also experienced more minor to moderate symptoms and side effects. in a commentary accompanying the new study, Erin McCreary and Derek Angus, two researchers at the University of Pittsburgh Medical Center, said the new findings raise a question about "whether the drug is less efficacious than hoped."
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼